-
-
-
-
-
-
-
Notable Analyst Rating Changes 07/23: (MDC) (ONXX) (BYD) Upgraded; (MAR) (VRSN) (WAG) Downgraded
-
-
-
-
-
-
-
Baird Reiterates a 'Neutral' on Onyx Pharmaceuticals (ONXX); Lightning Strikes: Regorafenib CRC Success Adds Meaningfully to Valuation
-
-
-
-
-
-
-
Onyx Pharma (ONXX) calls active on positive Nexavar Phase 2 data
-
-
27,746 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

